RASSF5 and ovarian carcinoma: Further analyses confirmed that RASSF5 expression increases in TET1-overexpressing ovarian cancer cells, but the obtained results suggested that other TET1 downstream targets may also mediate the effects of this molecule on ovarian cancer cell proliferation and colony forming ability.